126 related articles for article (PubMed ID: 1394437)
1. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice.
Carlsten H; Nilsson N; Jonsson R; Bäckman K; Holmdahl R; Tarkowski A
Cell Immunol; 1992 Oct; 144(1):190-202. PubMed ID: 1394437
[TBL] [Abstract][Full Text] [Related]
2. Expression of heterozygous lpr gene in MRL mice. II. Acceleration of glomerulonephritis, sialadenitis, and autoantibody production.
Carlsten H; Tarkowski A; Jonsson R; Nilsson LA
Scand J Immunol; 1990 Jul; 32(1):21-8. PubMed ID: 2382106
[TBL] [Abstract][Full Text] [Related]
3. Histocompatibility complex gene products and exposure to oestrogen: two independent disease accelerating factors in murine lupus.
Carlsten H; Tarkowski A
Scand J Immunol; 1993 Oct; 38(4):341-7. PubMed ID: 8210997
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of oestrogen in murine lupus: acceleration of glomerulonephritis and amelioration of T cell-mediated lesions.
Carlsten H; Nilsson N; Jonsson R; Tarkowski A
J Autoimmun; 1991 Dec; 4(6):845-56. PubMed ID: 1812892
[TBL] [Abstract][Full Text] [Related]
5. Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis.
Igawa T; Nakashima H; Sadanaga A; Masutani K; Miyake K; Shimizu S; Takeda A; Hamano S; Yoshida H
Mod Rheumatol; 2009; 19(1):33-41. PubMed ID: 18779924
[TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical study of the submaxillaritis in MRL/1 mouse (lymphoproliferation and autoimmunity)].
Miyamoto H
Kanagawa Shigaku; 1989 Dec; 24(3):501-22. PubMed ID: 2535161
[TBL] [Abstract][Full Text] [Related]
7. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
Cruse JM; Lewis RE; Dilioglou S
Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362
[TBL] [Abstract][Full Text] [Related]
8. Vasculitis-susceptible genes in mice with a deficit in Fas-mediated apoptosis.
Nose M; Terada M; Nishihara M; Kamogawa J; Miyazaki T; Mori S; Nishimura M; Wang Y; Kamoto T; Hiai H
Int J Cardiol; 1998 Oct; 66 Suppl 1():S37-41; discussion S43. PubMed ID: 9951801
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice.
Carlsten H; Tarkowski A; Holmdahl R; Nilsson LA
Clin Exp Immunol; 1990 Jun; 80(3):467-73. PubMed ID: 2372993
[TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo effects of pentoxifylline on macrophages and lymphocytes derived from autoimmune MRL-lpr/lpr mice.
Hecht M; Müller M; Lohmann-Matthes ML; Emmendörffer A
J Leukoc Biol; 1995 Feb; 57(2):242-9. PubMed ID: 7852838
[TBL] [Abstract][Full Text] [Related]
12. An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice.
Mihara M; Nakano T; Ohsugi Y
Clin Immunol Immunopathol; 1987 Dec; 45(3):366-74. PubMed ID: 3500002
[TBL] [Abstract][Full Text] [Related]
13. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
Hoi AY; Hickey MJ; Hall P; Yamana J; O'Sullivan KM; Santos LL; James WG; Kitching AR; Morand EF
J Immunol; 2006 Oct; 177(8):5687-96. PubMed ID: 17015758
[TBL] [Abstract][Full Text] [Related]
15. The Prostaglandin E(1) (PGE(1)) Analog Misoprostol Ameliorates Autoimmune Disease and Depletes T Lymphocytes in MRL-lpr/lpr Mice.
Best V; Ruiz P; Spurney RF
Am J Ther; 1995 Dec; 2(12):943-948. PubMed ID: 11854812
[TBL] [Abstract][Full Text] [Related]
16. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice.
Apelgren LD; Bailey DL; Fouts RL; Short L; Bryan N; Evans GF; Sandusky GE; Zuckerman SH; Glasebrook A; Bumol TF
Cell Immunol; 1996 Oct; 173(1):55-63. PubMed ID: 8871601
[TBL] [Abstract][Full Text] [Related]
17. Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice.
Theofilopoulos AN; Balderas RS; Shawler DL; Lee S; Dixon FJ
J Exp Med; 1981 Jun; 153(6):1405-14. PubMed ID: 6972998
[TBL] [Abstract][Full Text] [Related]
18. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
Watanabe H; Garnier G; Circolo A; Wetsel RA; Ruiz P; Holers VM; Boackle SA; Colten HR; Gilkeson GS
J Immunol; 2000 Jan; 164(2):786-94. PubMed ID: 10623824
[TBL] [Abstract][Full Text] [Related]
19. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
[TBL] [Abstract][Full Text] [Related]
20. Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-beta1 gene therapy using attenuated Salmonella typhimurium as gene carrier.
Huggins ML; Huang FP; Xu D; Lindop G; Stott DI
Lupus; 1999; 8(1):29-38. PubMed ID: 10025597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
